Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study

Current antiretroviral (ARV) therapy for the treatment of human immunodeficiency virus (HIV-1)-infected patients provides long-term control of viral load (VL). Darunavir (DRV) is a nonpeptidomimetic protease inhibitor approved for use with a ritonavir booster (DRV/r). This study evaluated the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Antinori, Andrea, Meraviglia, Paola, Monforte, Antonella d’Arminio, Castagna, Antonella, Mussini, Cristina, Bini, Teresa, Gianotti, Nicola, Rusconi, Stefano, Colella, Elisa, Airoldi, Giuseppe, Mancusi, Daniela, Termini, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866750/
https://www.ncbi.nlm.nih.gov/pubmed/27226708
http://dx.doi.org/10.2147/DDDT.S104875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866750/
https://www.ncbi.nlm.nih.gov/pubmed/27226708
http://dx.doi.org/10.2147/DDDT.S104875

Ejemplares similares